Table 1.
Study population characteristics
| End-stage renal disease patients not receiving renal replacement therapy | End-stage renal disease patients receiving renal replacement therapy | Healthy controls | ||||
|---|---|---|---|---|---|---|
| Group |
Young |
Old |
Young |
Old |
Young |
Old |
| Number of individuals |
22 |
33 |
49 |
49 |
55 |
65 |
| Age in Years |
33.5 ± 9.6* |
64.4 ± 6.3* |
35.7 ± 8.5* |
63.1 ± 8.7* |
38.4 ± 7.9* |
63.5 ± 7.5* |
| Male |
77.3% |
60.6% |
55.1% |
71.4% |
49.1% |
38.5% |
| CMV positive |
54.5% |
51.2% |
59.2% |
53.1% |
50.9% |
49.2% |
| Hemodialysis |
|
|
25 |
32 |
|
|
| Peritoneal dialysis |
|
|
24 |
17 |
|
|
| Duration of RRT (years) |
|
|
4.30 (0.1 - 22)** |
2.76 (0.2 - 18)** |
|
|
|
Underlying kidney disease |
|
|
|
|
|
|
| - Hypertensive nephropathy |
13.6% |
27.2% |
20.8% |
30.6% |
|
|
| - Primary glomerulopathy |
31.8% |
18.2% |
18.8% |
18.4% |
|
|
| - Diabetic nephropathy |
0% |
21.2% |
2.1% |
8.2% |
|
|
| - Polycystic kidney disease |
9.1% |
9.0% |
0% |
2.0% |
|
|
| - Reflux nephropathy |
18.2% |
3.0% |
14.6% |
4.1% |
|
|
| - Other |
9.1% |
15.2% |
20.9% |
8.2% |
|
|
| - Unknown | 18.2% | 6.0% | 22.9% | 28.6% | ||
* Data are given in means with standard deviation.
** Data are given in means with range.